Therefore, the present study aims to establish a murine model of NAFLD to evaluate changes in hepatic function and lipid metabolism following rhein treatment, and to explore the regulatory mechanism of rhein via the AMPK/ACC/SREBP1 signaling pathway. The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatotic liver disease.